Skip Navigation


Annals of Oncology Advance Access originally published online on September 15, 2005
Annals of Oncology 2006 17(2):349-350; doi:10.1093/annonc/mdj036
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
17/2/349    most recent
mdj036v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Oyan, B.
Right arrow Articles by Koc, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oyan, B.
Right arrow Articles by Koc, Y.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2005 European Society for Medical Oncology

letter to the editor

Is it time to discontinue using high-dose chemotherapy for salvage of patients with advanced germ-cell tumors failing first-line platinum chemotherapy?

The first 10% of the full text of this article appears below.

We read with interest the article by Pico et al. [1Go]. In their report, it was stated that a single cycle of high-dose chemotherapy (HDT) after three cycles of standard dose chemotherapy had no effect on treatment outcomes of patients with advanced germ-cell tumor failing first-line platinum chemotherapy compared with four cycles of standard dose . . . [Full Text of this Article]

B. Oyan1,* and Y. Koc1

1 Department of Medical Oncology, Faculty of Medicine, Yeditepe University, Icerenkoy Mah, Devletyolu, Ankara Cad. 102–104, Kozyatagi, Istanbul

* (E-mail: basakou@yahoo.com)


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?